Assessment of liver function by gadoxetic acid avidity in MRI in a model of rapid liver regeneration in rats
HPB · 2024
DOI: 10.1016/j.hpb.2023.12.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift HPB, 2024. Verfasst von Jan Heil und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Physiology, University of Zurich, Zurich, Switzerland; Goethe University Frankfurt, University Hospital, Department of General, Visceral…. Hauptthemen laut MEDLINE: Liver Regeneration, Liver Neoplasms, Gadolinium DTPA. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.
Abstract (Originalsprache)
BACKGROUND: This animal study investigates the hypothesis of an immature liver growth following ALPPS (associating liver partition and portal vein ligation for staged hepatectomy) by measuring liver volume and function using gadoxetic acid avidity in magnetic resonance imaging (MRI) in models of ALPPS, major liver resection (LR) and portal vein ligation (PVL). METHODS: Wistar rats were randomly allocated to ALPPS, LR or PVL. In contrast-enhanced MRI scans with gadoxetic acid (Primovist®), liver volume and function of the right median lobe (=future liver remnant, FLR) and the deportalized lobes (DPL) were assessed until post-operative day (POD) 5. Liver functionFLR/DPL was defined as the inverse value of time from injection of gadoxetic acid to the blood pool-corrected maximum signal intensityFLR/DPL multiplied by the volumeFLR/DPL. RESULTS: In ALPPS (n = 6), LR (n = 6) and PVL (n = 6), volumeFLR and functionFLR increased proportionally, except on POD 1. Thereafter, functionFLR exceeded volumeFLR increase in LR and ALPPS, but not in PVL. Total liver function was significantly reduced after LR until POD 3, but never undercuts 60% of its pre-operative value following ALPPS and PVL. DISCUSSION: This study shows for the first time that functional increase is proportional to volume increase in ALPPS using gadoxetic acid avidity in MRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Physiology, University of Zurich, Zurich, Switzerland; Goethe University Frankfurt, University Hospital, Department of General, Visceral, Transplant and Thoracic Surgery, Germany.
- Institute for Biomedical Engineering, ETH Zurich, Zurich, Switzerland.
- The Interface Group, Institute of Physiology, University of Zurich, Zurich, Switzerland.
- Department of Radiology and Nuclear Medicine, Cantonal Hospital Winterthur, Winterthur, Switzerland; Medical Faculty, University of Basel, Basel, Switzerland.
- Goethe University Frankfurt, University Hospital, Department of General, Visceral, Transplant and Thoracic Surgery, Germany.
- Department of Surgery, Erasmus MC, Rotterdam, the Netherlands; Department of Surgery, Amsterdam UMC, Amsterdam, the Netherlands.
Förderung
- Deutsche Forschungsgemeinschaft
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Zitieren
APA
Heil, J., Augath, M., Kurtcuoglu, V., Hohmann, J., Bechstein, W. O., Olthof, P., Schnitzbauer, A. A., Seebeck, P., Schiesser, M., Schläpfer, M., Beck-Schimmer, B., & Schadde, E. (2024). Assessment of liver function by gadoxetic acid avidity in MRI in a model of rapid liver regeneration in rats. HPB. https://doi.org/10.1016/j.hpb.2023.12.007
Vancouver
Heil J, Augath M, Kurtcuoglu V, Hohmann J, Bechstein WO, Olthof P, et al. Assessment of liver function by gadoxetic acid avidity in MRI in a model of rapid liver regeneration in rats. HPB. 2024. doi:10.1016/j.hpb.2023.12.007
BibTeX
@article{Heil2024,
author = {Heil, Jan and Augath, Mark and Kurtcuoglu, Vartan and Hohmann, Joachim and Bechstein, Wolf O and Olthof, Pim and Schnitzbauer, Andreas A and Seebeck, Petra and Schiesser, Marc and Schläpfer, Martin and Beck-Schimmer, Beatrice and Schadde, Erik},
title = {Assessment of liver function by gadoxetic acid avidity in MRI in a model of rapid liver regeneration in rats},
journal = {HPB},
year = {2024},
doi = {10.1016/j.hpb.2023.12.007}
}
EUVIMED